Well keep this page updated as robust data emerges from Retatrutide clinical trials and UK regulators release guidance
This dual mechanism introduces a unique axis for scientific exploration, particularly when applied to studies around glucose control, insulin sensitivity, and appetite regulation
This is where peptides can play a role
SUSTAIN-7 (N=1,201), a head-to-head trial against dulaglutide, reported mean weight loss of 5.5 to 7.3 kg at the 1 mg dose over 40 weeks, with A1C reductions of 1.8% from a baseline of approximately 8.2% 3
However, results can vary from person to person, and it is crucial to consult with a healthcare professional before beginning any new supplement regimen
For foot cramps, spread your toes and flex the foot